Stay updated on M7824 and Topotecan in Relapsed SCLC Clinical Trial
Sign up to get notified when there's something new on the M7824 and Topotecan in Relapsed SCLC Clinical Trial page.

Latest updates to the M7824 and Topotecan in Relapsed SCLC Clinical Trial page
- CheckyesterdayChange DetectedAdds 'No longer looking for participants' and new help/navigation sections ('How to Read a Study Record', 'Common Questions', 'How to Join a Study') along with an 'Intervention/Treatment' section, and removes the old 'Intervention / Treatment' heading and the 'Revision: v3.5.5' note; a 'Revision: v3.6.0' update is included.SummaryDifference0.3%

- Check8 days agoChange DetectedRevision updated from v3.5.4 to v3.5.5, signaling a routine backend/software update to the page.SummaryDifference0.0%

- Check15 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedRevision tag updated from v3.5.3 to v3.5.4 within the study record, indicating a minor version update to the page documentation. This change is a metadata update and does not modify the study content or results.SummaryDifference0.0%

- Check51 days agoChange DetectedThe page’s revision/version indicator was updated from v3.5.2 to v3.5.3.SummaryDifference0.0%

- Check58 days agoChange DetectedAdded Revision: v3.5.2; Deleted Revision: v3.5.0.SummaryDifference0.0%

- Check79 days agoChange DetectedAdded the term Small cell lung carcinoma to the glossary and introduced a Resources section featuring the Genetic and Rare Diseases Information Center.SummaryDifference0.1%

Stay in the know with updates to M7824 and Topotecan in Relapsed SCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the M7824 and Topotecan in Relapsed SCLC Clinical Trial page.